These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
120 related articles for article (PubMed ID: 7284118)
1. [In vitro cytolysis mediated by NK effectors: modification of the susceptibility of the target cell by in vivo treatment with DTIC]. Migliorati G; Romani L; Fioretti MC Boll Soc Ital Biol Sper; 1981 May; 57(9):1024-30. PubMed ID: 7284118 [TBL] [Abstract][Full Text] [Related]
2. Murine natural antitumor antibodies. III. Interferon treatment of a natural killer-resistant lymphoma: augmentation of natural antibody reactivity and susceptibility to in vivo natural resistance. Miller VE; Pohajdak B; Greenberg AH J Natl Cancer Inst; 1983 Aug; 71(2):377-84. PubMed ID: 6576195 [TBL] [Abstract][Full Text] [Related]
3. Interferon and butyrate treatment leads to a decreased sensitivity of NK target cells to lysis by homologous but not by heterologous effector cells. Laskay T; Kiessling R Nat Immun Cell Growth Regul; 1986; 5(4):211-20. PubMed ID: 3095635 [TBL] [Abstract][Full Text] [Related]
4. Antileukemia activity of a natural killer cell line against human leukemias. Yan Y; Steinherz P; Klingemann HG; Dennig D; Childs BH; McGuirk J; O'Reilly RJ Clin Cancer Res; 1998 Nov; 4(11):2859-68. PubMed ID: 9829753 [TBL] [Abstract][Full Text] [Related]
5. Susceptibility of murine lymphoma cells treated with 5-(3,3-dimethyl-1-triazenyl)-1H-imidazole-4-carboxamide to NK-mediated cytotoxicity in vitro. Romani L; Migliorati G; Bonmassar E; Fioretti MC Int J Immunopharmacol; 1983; 5(4):299-306. PubMed ID: 6629590 [TBL] [Abstract][Full Text] [Related]
6. Transplantability and sensitivity to natural killer cells of aclarubicin-resistant murine lymphoma. Sugimoto Y; Hirakawa Y; Tanaka N; Tahara M; Sato I; Nishimura T; Suzuki H; Tanaka N Cancer Res; 1986 Nov; 46(11):5646-8. PubMed ID: 3463416 [TBL] [Abstract][Full Text] [Related]
7. Susceptibility of Adenovirus 2-transformed rat cell lines to natural killer (NK) cells: direct correlation between NK resistance and in vivo tumorigenesis. Sheil JM; Gallimore PH; Zimmer SG; Sopori ML J Immunol; 1984 Mar; 132(3):1578-82. PubMed ID: 6319497 [TBL] [Abstract][Full Text] [Related]
8. Phenotypic alterations in tumors that developed from threshold subcutaneous inocula. I. Reduced binding of natural antibodies and sensitivity to hypotonic lysis. Brown GW; Lesiuk TP; Chow DA J Immunol; 1986 Apr; 136(8):3116-23. PubMed ID: 3958491 [TBL] [Abstract][Full Text] [Related]
9. In vitro generation of primary cytotoxic lymphocytes against L5178Y leukemia antigenically altered by 5-(3,3'-dimethyl-1-triazeno)-imidazole-4-carboxamide in vivo. Romani L; Fioretti MC; Bonmassar E Transplantation; 1979 Sep; 28(3):218-22. PubMed ID: 494379 [TBL] [Abstract][Full Text] [Related]
10. Tumor selection in vivo for reduced sensitivity to natural resistance and natural antibodies. Chow DA J Natl Cancer Inst; 1984 Feb; 72(2):339-46. PubMed ID: 6582320 [TBL] [Abstract][Full Text] [Related]
11. VLA-6 (CDw49f) is an important adhesion molecule in NK cell-mediated cytotoxicity following autologous or allogeneic bone marrow transplantation. Lowdell MW; Shamim F; Hamon M; Macdonald ID; Prentice HG Exp Hematol; 1995 Dec; 23(14):1530-4. PubMed ID: 8542943 [TBL] [Abstract][Full Text] [Related]
12. Drug-induced immunogenic changes of murine leukemia cells: dissociation of onset of resistance and emergence of novel immunogenicity. Fioretti MC; Bianchi R; Romani L; Bonmassar E J Natl Cancer Inst; 1983 Dec; 71(6):1247-51. PubMed ID: 6581361 [TBL] [Abstract][Full Text] [Related]
13. Antibody-dependent cellular cytotoxicity against drug-induced antigens in L5178Y mouse lymphoma. Franco P; Veronese F; Levi F; Goldin A; Nicolin A Br J Cancer; 1982 Aug; 46(2):173-9. PubMed ID: 7150471 [TBL] [Abstract][Full Text] [Related]
14. Monoclonal antibodies to the L1210 murine leukemia cell line and to a drug-altered subline. Testorelli C; Archetti YL; Aresca P; Del Vecchio L Cancer Res; 1985 Nov; 45(11 Pt 1):5299-303. PubMed ID: 4053006 [TBL] [Abstract][Full Text] [Related]
15. A search for target cell structures associated with susceptibility to NK cells. Henney CS Adv Exp Med Biol; 1982; 146():357-66. PubMed ID: 7102463 [No Abstract] [Full Text] [Related]
16. In vivo lysis of L5178Y cells in the establishment of the tumor-dormant state in DBA/2 mice. Wheelock EF; Weinhold KJ; Ingenito GG; Goldstein LT J Immunol; 1980 Apr; 124(4):1642-7. PubMed ID: 7365237 [No Abstract] [Full Text] [Related]
17. In vitro and in vivo characteristics of human squamous cell carcinoma of the head and neck cells engineered to secrete interleukin-2. Nagashima S; Reichert TE; Kashii Y; Suminami Y; Chikamatsu K; Whiteside TL Cancer Gene Ther; 1997; 4(6):366-76. PubMed ID: 9408607 [TBL] [Abstract][Full Text] [Related]
18. Expression of normal histocompatibility antigens in murine lymphomas treated with 5-(3,3'-dimethyl-1-triazeno)-imidazole-4-carboxamide (DTIC) in vivo. Taramelli D; Romani L; Bonmassar A; Goldin A; Fioretti MC Eur J Cancer (1965); 1981 Apr; 17(4):411-20. PubMed ID: 6171429 [No Abstract] [Full Text] [Related]
19. Natural cytotoxic cells against solid tumors in mice. IV. Natural cytotoxic (NC) cells are not activated natural killer (NK) cells. Lattime EC; Pecoraro G; Stutman O Int J Cancer; 1982 Oct; 30(4):471-7. PubMed ID: 7141742 [TBL] [Abstract][Full Text] [Related]
20. The mechanism of augmentation of natural killer cell activity by syngeneic tumor cells: role of macrophage-derived factor in NK boosting. Kawase I; Urdal DL; Newman W; Henney CS Int J Cancer; 1983 Mar; 31(3):365-72. PubMed ID: 6402456 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]